Today's announcement is a clear demonstration IMO that Starpharma and its previous CEO Jackie Fairley struggled at every turn with multiple regulators across multiple continents
2018 - FDA CRL
2024 - FDA Appeal Rejection
2021 - MHRA Withdrawal of stock from Pharmacy shelves
2022 - MHRA Viraleze returns to pharmacy shelves but with no COVID-19 claims allowed
2021 - TGA Viraleze Fines
2022 - TGA Medical Device Classification Saga
2024 - TGA still no approval for Viraleze well outside of guidelines / timeframes
.... but hey I am sure there were multiple KPI's hit and freebie shares dolled out for these failures and regulatory body interactions along the way ?
Today's announcement is a clear demonstration IMO that...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
